Top Markets
Coin of the day
Hepion Pharmaceuticals, Inc. Hepion Pharmaceuticals, Inc.

Hepion Pharmaceuticals, Inc.

HEPA
Ранг среди акций #39072
Hepion Pharmaceuticals, Inc., a U.S.-based biopharmaceutical entity, is... Hepion Pharmaceuticals, Inc., a U.S.-based biopharmaceutical entity, is dedicated to developing therapeutic interventions for chronic hepatic ailments. Central to their efforts is Rencofilstat, a cyclophilin inhibitor that has successfully concluded Phase 2a clinical trials. This compound operates by disrupting multiple pathological pathways implicated in the worsening of liver disease. It is currently progressing through clinical development for non-alcoholic steatohepatitis (NASH) and is additionally being explored in nonclinical research for its potential to reduce liver fibrosis and lessen hepatocellular carcinoma tumor loads in experimental models of NASH. Moreover, Rencofilstat has exhibited antiviral properties against hepatitis B, C, and D viruses through diverse mechanisms. The company, established in 2013 and situated in Edison, New Jersey, rebranded as Hepion Pharmaceuticals, Inc. in July 2019, having previously operated as ContraVir Pharmaceuticals, Inc.
Цена акции
$0.0568
Последняя синхронизация: 2026-08-13
Рыночная капитализация
$661.36K
Изменение (1 день)
11.37%
Изменение (1 год)
-5.33%
Страна
US
Торговля Hepion Pharmaceuticals, Inc. (HEPA)

Категория

История цены акций Hepion Pharmaceuticals, Inc. (HEPA)
Наивысшая цена закрытия: $0.05 2026-08-01

Наименьшая цена закрытия: $815.99K 2014-02-01
История цены акций Hepion Pharmaceuticals, Inc. с 2014 по 2026
Годовая динамика цены акций
Год Результативность
2026 (TTM) -13.53%
2025 -99.75%
2024 -83.90%
2023 -47.81%
2022 -72.98%
2021 -35.82%
2020 -64.66%
2019 -80.01%
2018 -87.43%
2017 -77.91%
2016 -3.97%
2015 1.80%
2014 0.00%
Цена акций похожих компаний или конкурентов
Компания Цена акций Изменение 1г% Страна
$517.18 32.51%
US
$857.76 31.47%
NL
$728.05 6.60%
CH
$1.07K -6.40%
KR
$254.79 12.56%
BE